MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers

Aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane have shown to prevent metastasis and angiogenesis in estrogen receptor (ER)-positive breast and ovarian tumors. They function primarily by reducing estrogen production in ER-positive post-menopausal breast and ovarian cancer p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Mol Sci
Päätekijät: Barwal, Tushar Singh, Sharma, Uttam, Bazala, Sonali, Singh, Ipsa, Jain, Manju, Prakash, Hridayesh, Shekhar, Shashank, Sandberg, Elise N., Bishayee, Anupam, Jain, Aklank
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MDPI 2021
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8071157/
https://ncbi.nlm.nih.gov/pubmed/33920789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22084072
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia